Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP937287.RAAdsrkIAW5EovdIF_WS1agE3CDcw9QB4QkMLQWrFYTPQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP937287.RAAdsrkIAW5EovdIF_WS1agE3CDcw9QB4QkMLQWrFYTPQ130_assertion type Assertion NP937287.RAAdsrkIAW5EovdIF_WS1agE3CDcw9QB4QkMLQWrFYTPQ130_head.
- NP937287.RAAdsrkIAW5EovdIF_WS1agE3CDcw9QB4QkMLQWrFYTPQ130_assertion description "[Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP937287.RAAdsrkIAW5EovdIF_WS1agE3CDcw9QB4QkMLQWrFYTPQ130_provenance.
- NP937287.RAAdsrkIAW5EovdIF_WS1agE3CDcw9QB4QkMLQWrFYTPQ130_assertion evidence source_evidence_literature NP937287.RAAdsrkIAW5EovdIF_WS1agE3CDcw9QB4QkMLQWrFYTPQ130_provenance.
- NP937287.RAAdsrkIAW5EovdIF_WS1agE3CDcw9QB4QkMLQWrFYTPQ130_assertion SIO_000772 22069160 NP937287.RAAdsrkIAW5EovdIF_WS1agE3CDcw9QB4QkMLQWrFYTPQ130_provenance.
- NP937287.RAAdsrkIAW5EovdIF_WS1agE3CDcw9QB4QkMLQWrFYTPQ130_assertion wasDerivedFrom befree-2016 NP937287.RAAdsrkIAW5EovdIF_WS1agE3CDcw9QB4QkMLQWrFYTPQ130_provenance.
- NP937287.RAAdsrkIAW5EovdIF_WS1agE3CDcw9QB4QkMLQWrFYTPQ130_assertion wasGeneratedBy ECO_0000203 NP937287.RAAdsrkIAW5EovdIF_WS1agE3CDcw9QB4QkMLQWrFYTPQ130_provenance.